Medisan(SZ:002900) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-09-29 01:32Core Viewpoint - The company has successfully achieved the conditions for the third unlock period of its 2022 restricted stock incentive plan, allowing 166 eligible participants to unlock a total of 1,963,555 shares, which represents 0.6207% of the company's total share capital [2][16][18]. Summary by Sections Incentive Plan Overview - The 2022 restricted stock incentive plan was approved on July 29, 2022, with the first grant date set for August 29, 2022, and the first unlock date for September 30, 2025 [3][5][10]. Unlock Conditions - The unlock conditions for the third period have been met, allowing 166 participants to unlock 1,963,555 shares [2][16][19]. - The shares will be available for trading starting from October 9, 2025 [16]. Adjustments and Changes - The total number of eligible participants has changed from 177 to 176 due to one participant's departure, resulting in a reduction of the total shares granted from 6,815,183 to 6,775,183 [11][12]. - The repurchase price for the restricted shares has been adjusted multiple times, currently set at 6.48 yuan per share [14]. Legal and Compliance - The company has obtained necessary approvals and legal opinions confirming compliance with relevant regulations regarding the incentive plan and share repurchase [18][19]. - The independent financial advisor has stated that the actions taken do not harm the interests of the company or its shareholders [19]. Board and Committee Opinions - The board's remuneration and assessment committee, as well as the independent directors, have confirmed the legitimacy of the unlock conditions and the eligibility of the participants [17][18].